Skip to main content
SpringerLink
Log in

Diagnosis and Evaluation of Gallbladder Cancer

  • Reference work entry
  • First Online:
Hepato-Pancreato-Biliary Malignancies

  • 667 Accesses

Abstract

Gallbladder cancer is a malignancy of the biliary tract which is not frequent in well-developed countries but common in developing countries. Late diagnosis and poor prognosis are the main problems for the treatment of gallbladder carcinoma (GBC).

The absence of a serosal shield of the gallbladder neighboring to the liver can enable hepatic invasion, and metastatic progression is one of the major causes of its low survival [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 329.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99–109.

    Google Scholar 

  2. Shaffer EA. Gallbladder cancer: the basics. Gastroenterol Hepatol (N Y). 2008;4:737–41.

    Google Scholar 

  3. Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for gallbladder cancer across the world. HPB (Oxford). 2008;10:327–31.

    Article  CAS  Google Scholar 

  4. Wi YJ, Woo HT, Won YJ, Jang JY, Shin AS. Trends in gallbladder cancer incidence and survival in Korea. Cancer Res Treat. 2018;50(4):1444–51.

    Article  Google Scholar 

  5. Pilgrim CH, Groeschl RT, Christians KK, Gamblin TC. Modern perspectives on factors predisposing to the development of gallbladder cancer. HPB (Oxford). 2013;15:839–44.

    Article  Google Scholar 

  6. Jain K, Sreenivas V, Velpandian T, Kapil U, Garg PK. Risk factors for gallbladder cancer: a case-control study. Int J Cancer. 2013;132:1660–6.

    Article  CAS  Google Scholar 

  7. Hsing AW, Bai Y, Andreotti G, Rashid A, Deng J, Chen J, Goldstein AM, Han TQ, Shen MC, Fraumeni JF, Gao YT. Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China. Int J Cancer. 2007;121:832–8.

    Article  CAS  Google Scholar 

  8. Jackson HH, Glasgow RE, Mulvihill SJ, Cannon-Albright LA. Familial risk in gallbladder cancer. J Am Coll Surg. 2007;205:S38–S138.

    Article  Google Scholar 

  9. Hemminki K, Li X. Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden. Gut. 2003;52:592–6.

    Article  CAS  Google Scholar 

  10. Albores-Saavedra J, Alcántra-Vazquez A, Cruz-Ortiz H, HerreraGoepfert R. The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer. 1980;45:919–27.

    Article  CAS  Google Scholar 

  11. Roa I, Araya JC, Villaseca M, De Aretxabala X, Riedemann P, Endoh K, Roa J. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology. 1996;111:232–6.

    Article  CAS  Google Scholar 

  12. D'Hondt M, Lapointe R, Benamira Z, et al. Carcinoma of the gallbladder: patterns of presentation, prognostic factors and survival rate. An 11-year single centre experience. Eur J Surg Oncol. 2013;39:548–53.

    Article  CAS  Google Scholar 

  13. Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485–9.

    Article  CAS  Google Scholar 

  14. Fuks D, Regimbeau JM, Le Treut YP, et al. Incidental gallbladder cancer by the AFC-GBC-2009 study group. World J Surg. 2011;35:1887–97.

    Article  Google Scholar 

  15. Park JY, Hong SP, Kim YJ, et al. Long-term follow up of gallbladder polyps. J Gastroenterol Hepatol. 2009;24:219–22.

    Article  Google Scholar 

  16. Fong Y, Jarnagin W, Blumgart LH. Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg. 2000;232:557–69.

    Article  CAS  Google Scholar 

  17. Aloia TA, Jarufe N, Javle M, et al. Gallbladder cancer: expert consensus statement. HPB (Oxford). 2015;17:681–90.

    Article  Google Scholar 

  18. Chijiiwa K, Noshiro H, Nakano K, et al. Role of surgery for gallbladder carcinoma with special reference to lymph node metastasis and stage using Western and Japanese classification systems. World J Surg. 2000;24:1271–6; Discussion 1277

    Article  CAS  Google Scholar 

  19. Kishi Y, Shimada K, Hata S, et al. Definition of T3/4 and regional lymph nodes in gallbladder cancer: which is more valid, the UICC or the Japanese Staging System? Ann Surg Oncol. 2012;19:3567–73.

    Article  Google Scholar 

  20. Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K. Extent of lymph node dissection in patients with gallbladder cancer. Br J Surg. 2018;105(12):1658–1664.

    Google Scholar 

  21. Shroff RT, Javle MM, Xiao L, et al. Gemcitabine, Cisplatin, and nab-Paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial. JAMA Oncol. 2019;5:824–30.

    Article  Google Scholar 

  22. Goff LW, Lowery MA, Jordan E, et al. Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): a retrospective multicenter analysis. J Clin Oncol. 2016;34:437.

    Article  Google Scholar 

  23. Javle MM, Hainsworth JD, Swanton C, et al. Pertuzumab + trastuzumab for HER2-positive metastatic biliary cancer: preliminary data from MyPathway. J Clin Oncol. 2017;35:402.

    Article  Google Scholar 

  24. Ueno M, Chung HC, Nagrial A, et al. Pembrolizumab for advanced biliary adenocarcinoma: results from the multicohort, phase 2 KEYNOTE-158 study. Ann Oncol. 2018;29:viii205–70.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor of Surgery; Private Clinician, Hepatopancreatobiliary Surgery, Izmir, Turkey

    Unal Aydin

Authors
  1. Unal Aydin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Unal Aydin .

Editor information

Editors and Affiliations

  1. Medical Director, Capital Health Cancer Center, Director, CH Pancreas Center of Excellence, Director, CH Liver Center of Excellence, Pennington, NJ, USA

    Cataldo Doria

  2. Director of Interventional Gastroenterology, Capital Health Medical Center, Pennington, NJ, USA

    Jason N. Rogart

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Aydin, U. (2022). Diagnosis and Evaluation of Gallbladder Cancer. In: Doria, C., Rogart, J.N. (eds) Hepato-Pancreato-Biliary Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-030-41683-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-41683-6_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-41682-9

  • Online ISBN: 978-3-030-41683-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation